References
- Castelli W P, Doyle J T, Gordon T, Hames C G, Hjortland M C, Hulley S B, Kagan A, Zukel W J. HDL cholesterol and other lipids in coronary heart disease—cooperative lipoprotein phenotyping study. Circulation 1977; 55: 767–72
- McGill H C, Jr. Persistent problems in the pathogenesis of atherosclerosis. Arteriosclerosis 1984; 4: 443–51
- Schneider J, Boldt J, Leyhe A, Kaffarnik H. HDL cholesterol, peripheral and coronary vascular disease in high age groups. Atherosclerosis 1980; 35: 487–9
- Lippel K, Tyroler H, Eder H, Gotto A, Jr, Vahouny G. Relationship of hypertriglyceridemia to atherosclerosis. Arteriosclerosis 1981; 1: 406–17
- Gillibrand D, Grewall D, Blatter D P. Chemistry reference values as a function of age and sex, including pediatric and geriatric subjects. Aging—its chemistry. Proceedings of the Third Arnold O. Beckman Conference in Clinical Chemistry. The American Association of Clinical Chemistry. 1980, A A Dietz. 366–89
- Rifkind B M, Segal P. Lipid research clinics program reference values for hyperlipidemia and hypolipidemia. JAMA 1983; 250: 1869–72
- West D W, Ash O. Adult reference intervals for 12 chemistry analytes: influences of age and sex. Am J Clin Pathol 1984; 81: 71–6
- Kostner G M. Enzymatic determination of cholesterol in high‐density lipoprotein fractions prepared polyanion precipitation. Clin Chem 1972; 22: 695
- Lehtonen A, Inberg M, Marniemi J, Maatela J, Alanen E. Serum lipid and apolipoprotein Al and B levels and their discriminative values in patients with coronary by‐pass operation. Atherosclerosis
- Friedewald W T, Levy R I, Fredrickson D S. Estimation of the concentration of low‐density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502
- Searle S R. Linear models. John Wiley & Sons Inc, New York 1971
- Solberg H E. The theory of reference values. Part 5. Statistical treatment of collected reference values. Determination of reference limits. Clin Chim Acta 1984; 137: 97F–114F
- Aromaa A, Björksten F, Eriksson A W, Maatela J, Kirjarinta M, Fellman J, Tamminen M. Serum cholesterol and triglyceride concentrations of Finns and Finnish Lapps. Acta Med Scand 1975; 198: 13–22
- Nicholson J, Gartside P S, Siegel M, Spencer W, Steiner P M, Glueck C J. Lipid and lipoprotein distributions in octo‐ and nonagenarians. Metabolism 1979; 28: 51–5
- Haavisto M, Mattila K. People over 85 years of age in the town of Tampere—medical examination and laboratory findings. J Soc Med 1982; 19: 264–75
- Schneider J. Lipid‐ and lipoprotein values in octo‐and nonagenarians free from overt degenerative arterial disease. Clin Chim Acta 1984; 143: 1–5
- Levine R. Carbohydrate and lipid metabolism in the aged. Aging—its chemistry. Proceedings of the Third Arnold O. Beckman Conference in Clinical Chemistry. The American Association for Clinical Chemistry. 1980, A A Dietz. 366–89
- Alvarez C, Orejas A, Gonzales S, Diaz R, Golomo L F. Reference intervals for serum lipids, lipoproteins and apolipoproteins in the elderly. Clin Chem 1984; 30: 404–6
- Avogaro P, Bittolo Bon G, Cazzolato G, Quinci G B. Are apolipoproteins better discriminators than lipids for atherosclerosis?. Lancet 1979; i: 901–3
- Kukita H, Hiwada K, Kokubu T. Serum apolipoprotein A‐I, A‐II and B levels and their discriminative values in relatives of patients with coronary artery disease. Atherosclerosis 1984; 51: 261–7
- Lehtonen A, Hietanen E, Marniemi J, Peltonen P, Niskanen J. Effect of pindolol on serum lipids and lipid metabolizing enzymes. Br J Clin Pharmac 1982; 13: 445s–8s
- Weidmann P, Gerber A, Mordasini R. Effects of antihypertensive therapy on serum lipoproteins. Hypertension 1983; 5(Suppl. III)III 120–III 131